Related Experiment Video
Updated: Aug 25, 2025
09:29
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
2.3K
Mobile phone applications to support psychotropic tapering: a scoping review protocol
Miriam Boland1, Agnes Higgins2, Gavin Doherty3
1School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland.
HRB Open Research
|October 18, 2022
Summary
This review examines mobile apps for tapering psychotropic medication. It identifies current resources and guides future development of digital tools to support safe medication discontinuation.
Area of Science:
- Mental Health
- Digital Health
- Pharmacology
Background:
- Recovery-oriented mental healthcare questions long-term psychotropic medication use.
- Supporting safe discontinuation of psychotropic medication is essential to minimize withdrawal and relapse.
- Service users increasingly seek online resources for tapering support due to a lack of formal interventions.
Purpose of the Study:
- To conduct a scoping review of mobile phone applications and app-based interventions for psychotropic tapering.
- To examine the content, evidence base, and impact of these digital tools.
- To identify gaps and inform future research in app-based psychotropic discontinuation support.
Main Methods:
- Scoping review following Joanna Briggs Institute guidance and PRISMA-ScR.
- Comprehensive searches of academic databases (MEDLINE, EMBASE, etc.) and app stores (Apple, Google Play) from 2008 onwards.
- Extraction and narrative synthesis of data, with app content coded using the Behaviour Change Technique (BCT) Taxonomy.
Main Results:
- A broad overview of available mobile applications designed to support psychotropic tapering.
- Analysis of app content, including the application of Behaviour Change Techniques.
- Identification of the current evidence base and potential impact of these digital interventions.
Conclusions:
- This review provides a comprehensive summary of existing apps for psychotropic tapering.
- Findings will inform the development, implementation, and evaluation of future app-based interventions.
- Highlights the need for evidence-based digital tools to support safe medication discontinuation in mental healthcare.
Keywords:
Psychotropicantidepressantsantipsychoticsbenzodiazepinesdiscontinuationmental disordersscoping reviewsmartphone appstaperingwithdrawalMore Related Videos
05:52Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
15.0K
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
9.9K
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
310
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
310
01:28Drug Therapy
89
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
89
01:26Psychosis: Goals of Pharmacotherapy
190
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
190
01:17Drug Dependence
1.1K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.1K
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
231
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
231
01:26Anxiolytic Drugs: Overview
436
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
436